Cell Therapy Group (CTG) was founded in 2008 by Lee Buckler to meet the demand for business-focused services in the cell-based regenerative medicine sector.
With over 20 years of experience, CTG has worked for founder startups and top-10 pharma companies, done deals in Europe, Israel, North America, and Asia.
In 2022, CTG was merged into HighMont Advisors, Inc. to expand the business and add it to a growing roster of strategic management consulting services focused on supporting companies in transition.
HighMont's CTG excels at:
HighMont's CTG likes to focus on companies in the cell therapy sector in transition due to growth, distress or disruption.
The group is quickly broadening its experience with cell therapy into the fast-emerging arena of cultured meat using cultured cells to manufacture a wide variety of meats using cultured animal cells but without sacrificing any animals. The growing interface between the cultured meat and cell therapy industries is of particular interest to this group.
You may know exactly what you need and how to get there but just need some extra hands to help you do it. If so, give us a call and let’s get started.
More likely you’d like to describe the challenges you’re facing and explore your options. We love those conversations. We have a lot of them. We’re happy to invest quite a bit of time understanding where you’re at and where you’d like the company to be before we charge a dime.
It starts with a conversation. Let’s have a call, zoom, or coffee.